These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19519175)

  • 21. Growth hormone receptor targeting to lipid rafts requires extracellular subdomain 2.
    Yang N; Jiang J; Deng L; Waters MJ; Wang X; Frank SJ
    Biochem Biophys Res Commun; 2010 Jan; 391(1):414-8. PubMed ID: 19914217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide.
    Langenheim JF; Chen WY
    J Endocrinol; 2009 Dec; 203(3):375-87. PubMed ID: 19770179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway.
    Rowlinson SW; Yoshizato H; Barclay JL; Brooks AJ; Behncken SN; Kerr LM; Millard K; Palethorpe K; Nielsen K; Clyde-Smith J; Hancock JF; Waters MJ
    Nat Cell Biol; 2008 Jun; 10(6):740-7. PubMed ID: 18488018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2.
    Swaminathan G; Varghese B; Thangavel C; Carbone CJ; Plotnikov A; Kumar KG; Jablonski EM; Clevenger CV; Goffin V; Deng L; Frank SJ; Fuchs SY
    J Endocrinol; 2008 Feb; 196(2):R1-7. PubMed ID: 18252943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MICA-G129R: A bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cells.
    Ding H; Buzzard GW; Huang S; Sehorn MG; Marcus RK; Wei Y
    PLoS One; 2021; 16(6):e0252662. PubMed ID: 34077462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.
    Lim JH; Kim TY; Kim WH; Park JW
    Breast Cancer Res Treat; 2011 Nov; 130(1):19-27. PubMed ID: 21128111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defects in growth hormone receptor signaling.
    Rosenfeld RG; Belgorosky A; Camacho-Hubner C; Savage MO; Wit JM; Hwa V
    Trends Endocrinol Metab; 2007; 18(4):134-41. PubMed ID: 17391978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular recognition events involved in the activation of the growth hormone receptor by growth hormone.
    Behncken SN; Waters MJ
    J Mol Recognit; 1999; 12(6):355-62. PubMed ID: 10611645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone signaling in fibroblasts from newborn boys and prepubertal boys.
    Ocaranza P; Morales F; Matamala Á; Gaete X; Román R; Lammoglia JJ; Cassorla F
    Growth Horm IGF Res; 2016 Apr; 27():18-27. PubMed ID: 26843474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRL/PRLR Can Promote Insulin Resistance by Activating the JAK2/STAT5 Signaling Pathway.
    Wang PY; Jin CC; Liu C; Zhao ZJ; Yang HY
    Comput Math Methods Med; 2022; 2022():1456187. PubMed ID: 36238467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of growth hormone receptors in human prostate cancer cell lines.
    Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
    Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolactin induces phosphorylation of the STAT5 in adrenal glands of Hatano rats during stress.
    Jaroenporn S; Nagaoka K; Ohta R; Watanabe G; Taya K
    Life Sci; 2009 Jul; 85(3-4):172-7. PubMed ID: 19481553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different intracellular signalling pathways triggered by an anti-prolactin receptor (PRLR) antibody: Implication for a signal-specific PRLR agonist.
    Kan QE; Su Y; Yang H; Man H
    Int J Biol Macromol; 2016 Jan; 82():892-7. PubMed ID: 26526176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.
    Langenheim JF; Chen WY
    Breast Cancer Res Treat; 2005 Apr; 90(3):281-93. PubMed ID: 15830142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolutionary origin and divergence of the growth hormone receptor family: insight from studies on sea lamprey.
    Ellens ER; Kittilson JD; Hall JA; Sower SA; Sheridan MA
    Gen Comp Endocrinol; 2013 Oct; 192():222-36. PubMed ID: 23726998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fos-Zippered GH Receptor Cytosolic Tails Act as Jak2 Substrates and Signal Transducers.
    Nespital T; van der Velden LM; Mensinga A; van der Vaart ED; Strous GJ
    Mol Endocrinol; 2016 Mar; 30(3):290-301. PubMed ID: 26859362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased growth hormone receptor (GHR) degradation due to over-expression of cytokine inducible SH2 domain-containing protein (CIS) as a cause of GH transduction defect (GHTD).
    Gil AP; Kostopoulou E; Karageorgou I; Kamzelas K; Spiliotis BE
    J Pediatr Endocrinol Metab; 2012; 25(9-10):897-908. PubMed ID: 23426819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent genes encoding the putative receptors for growth hormone and prolactin in sea lamprey display distinct patterns of expression.
    Gong N; Ferreira-Martins D; McCormick SD; Sheridan MA
    Sci Rep; 2020 Feb; 10(1):1674. PubMed ID: 32015405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone.
    van Agthoven J; Zhang C; Tallet E; Raynal B; Hoos S; Baron B; England P; Goffin V; Broutin I
    J Mol Biol; 2010 Nov; 404(1):112-26. PubMed ID: 20875426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prolactin receptor scaffolds Janus kinase 2 via co-structure formation with phosphoinositide-4,5-bisphosphate.
    Araya-Secchi R; Bugge K; Seiffert P; Petry A; Haxholm GW; Lindorff-Larsen K; Pedersen SF; Arleth L; Kragelund BB
    Elife; 2023 May; 12():. PubMed ID: 37232489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.